Mutations result either in the loss of function of TP53 as the central regulator of proliferation, apoptosis, as well as maintenance of genomic stability [1, 2], or in a gain-of-function that may contribute to tumor progression by conferring new oncogenic functions to the p53 protein resulting in enhanced proliferation, metastasis, and drug-resistance [6]. Here, TP53 is linked to neoplasm.